Zerebrale Marklagerhyperintensitäten in der Magnetresonanztomografie und deren klinische Relevanz

T. Gattringer; F. Fazekas

doi:10.1055/s-0034-1366703

Fortschritte der Neurologie · Psychiatrie, Table of Contents

Fortschr Neurol Psychiatr 2014; 82(8): 471-482
DOI: 10.1055/s-0034-1366703

Fort- und Weiterbildung

Zerebrale Marklagerhyperintensitäten in der Magnetresonanztomografie und deren klinische Relevanz

The Clinical Implication of Cerebral White Matter Hyperintensities on Magnetic Resonance Imaging

T. Gattringer

,

F. Fazekas

Abstract

Full Text

References

Literatur
1 Vernooij MW, Ikram MA, Tanghe HL et al. Incidental findings on brain MRI in the general population. N Engl J Med 2007; 357: 1821-1828
2 Wardlaw JM, Smith EE, Biessels GJ et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822-838
3 Fazekas F, Schmidt R, Kleinert R et al. The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates. J Neural Transm 1998; 53: S31-S39
4 Gouw AA, Seewann A, Vrenken H et al. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain 2008; 131: 3286-3298
5 Schmidt R, Schmidt H, Haybaeck J et al. Heterogeneity in age-related white matter changes. Acta Neuropathol 2011; 122: 171-185
6 Hachinski V, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987; 44: 21-23
7 Fazekas F, Kleinert R, Offenbacher H et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43: 1683-1689
8 Wardlaw JM. Blood-brain barrier and cerebral small vessel disease. J Neurol Sci 2010; 299: 66-71
9 Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9: 689-701
10 Fornage M, Debette S, Bis JC et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol 2011; 69: 928-939
11 Atwood L, Wolf P, Heard-Costa N et al. Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke 2004; 35: 1609-1613
12 Wardlaw JM, Allerhand M, Doubal FN et al. Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities. Neurology 2014; 82: 1331-1338
13 Fazekas F, Kleinert R, Offenbacher H et al. The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol 1991; 12: 915-921
14 Gouw AA, Seewann A, van der Flier WM et al. Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry 2011; 82: 126-135
15 Enzinger C, Smith S, Fazekas F et al. Lesion probability maps of white matter hyperintensities in elderly individuals: results of the Austrian stroke prevention study. J Neurol 2006; 253: 1064-1070
16 Fazekas F, Barkhof F, Filippi M et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 1999; 53: 448-456
17 Charil A, Yousry T, Rovaris M et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Lancet Neurol 2006; 5: 841-852
18 Auer DP, Putz B, Gossl C et al. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology 2001; 218: 443-451
19 Chabriat H, Joutel A, Dichgans M et al. Cadasil. Lancet Neurol 2009; 8: 643-653
20 Poggesi A, Pantoni L, Inzitari D et al. 2001–2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease?. Cerebrovasc Dis 2011; 32: 577-588
21 Inzitari D, Simoni M, Pracucci G et al. Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med 2007; 167: 81-88
22 Inzitari D, Pracucci G, Poggesi A et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 2009; 339: b2477
23 Fazekas F, Chawluk JB, Alavi A et al. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. Am J Roentgenol Am J Roentgenol 1987; 149: 351-356
24 Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010; 341: c3666
25 Schmidt R, Ropele S, Ferro J et al. Diffusion-weighted imaging and cognition in the leukoariosis and disability in the elderly study. Stroke 2010; 41: e402-e408
26 Ropele S, Seewann A, Gouw A et al. Quantitation of brain tissue changes associated with white matter hyperintensities by diffusion-weighted and magnetization transfer imaging: the LADIS (Leukoaraiosis and Disability in the Elderly) Study. J Magn Reson Imaging 2008; 29: 268-274
27 Gouw AA, van der Flier WM, Fazekas F et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008; 39: 1414-1420
28 Maillard P, Carmichael O, Harvey D et al. FLAIR and Diffusion MRI Signals Are Independent Predictors of White Matter Hyperintensities. AJNR Am J Neuroradiol 2013; 34: 54-61
29 Benisty S, Gouw AA, Porcher R et al. Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study. J Neurol Neurosurg Psychiatry 2009; 80: 478-483
30 Jokinen H, Gouw AA, Madureira S et al. Incident lacunes influence cognitive decline: the LADIS study. Neurology 2011; 76: 1872-1878
31 Schmidt R, Grazer A, Enzinger C et al. MRI-detected white matter lesions: do they really matter?. J Neural Transm 2011; 118: 673-681
32 Linortner P, Fazekas F, Schmidt R et al. White matter hyperintensities alter functional organization of the motor system. Neurobiol Aging 2012; 197: e1-e9
33 Lindley RI, Wang JJ, Wong MC et al. Retinal microvasculature in acute lacunar stroke: a cross-sectional study. Lancet Neurol 2009; 8: 628-634
34 Ikram MA, Vernooij MW, Hofman A et al. Kidney function is related to cerebral small vessel disease. Stroke 2008; 39: 55-61
35 Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317-1329
36 Álvarez-Sabín J, Maisterra O, Santamarina E et al. Factors influencing haemorrhagic transformation in ischaemic stroke. Lancet Neurol 2013; 12: 689-705
37 Palumbo V, Boulanger JM, Hill MD et al. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke. Neurology 2007; 68: 1020-1024
38 Neumann-Haefelin T, Hoelig S, Berkefeld J et al. Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke 2006; 37: 2463-2466
39 Pantoni L, Fierini F, Poggesi A. Thrombolysis in acute stroke patients with cerebral small vessel disease. Cerebrovasc Dis 2014; 37: 5-13
40 Shi ZS, Loh Y, Liebeskind DS et al. Leukoaraiosis predicts parenchymal hematoma after mechanical thrombectomy in acute ischemic stroke. Stroke 2012; 43: 1806-1811
41 Gratz PP, El-Koussy M, Hsieh K et al. Preexisting Cerebral Microbleeds on Susceptibility-Weighted Magnetic Resonance Imaging and Post-Thrombolysis Bleeding Risk in 392 Patients. Stroke 2014; [Epub ahead of print]
42 Shoamanesh A, Kwok CS, Lim PA et al. Postthrombolysis intracranial hemorrhage risk of cerebral microbleeds in acute stroke patients: a systematic review and meta-analysis. Int J Stroke 2013; 8: 348-356
43 Gorter JW. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology 1999; 53: 1319-1327
44 Smith EE, Rosand J, Knudsen KA et al. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 2002; 59: 193-197
45 Lee SH, Ryu WS, Roh JK. Cerebral microbleeds are a risk factor for warfarin-related intracerebral hemorrhage. Neurology 2009; 72: 171-176